Document is current
Any future updates will be listed below
-
Authors
Fernandez-Teruel, Carlos https://orcid.org/0000-0002-1473-2267
Cullberg, Marie https://orcid.org/0000-0003-1697-972X
Eberlein, Cath https://orcid.org/0000-0002-7357-7789
Barry, Simon T. https://orcid.org/0000-0002-8511-0588
Zhou, Diansong https://orcid.org/0000-0002-2673-1069
-
Funding
Funding for this research was provided by:
AstraZeneca
- License Information
-
More Information
Article History
Accepted: 21 July 2024
First Online: 10 August 2024
Declarations
:
: This study was funded by AstraZeneca, who also sponsored the open-access publication of the manuscript.
: Carlos Fernandez-Teruel, Marie Cullberg, Cath Eberlein, Simon T. Barry and Diansong Zhou were employees of AstraZeneca and may hold stocks and/or shares.
: All studies included in this analysis were approved by appropriate ethics committees and were conducted in accordance with the principles of the Declaration of Helsinki and the International Council on Harmonisation Good Clinical Practice guidelines.
: Written informed consent was obtained from all participants of the studies included in this analysis.
: Not applicable.
: Data underlying the findings described in this article may be obtained in accordance with AstraZeneca’s data-sharing policy, described at: .
: Not applicable.
: CF, MC, CE, SB and DZ designed the research, performed the research, analysed the data and wrote the manuscript. All authors read and approved the final version of the manuscript.
